Traditional Medicine in the Treatment of Drug Addiction

REFERENCES

• De Leon G. Therapeutic communities for addictions: A theoretical framework. Int J Addict 1995; 30: 1603–1645
   PubMedGoogle Scholar
• Etheridge R M, Craddock S G, Hubbard R L, Rounds-Bryant J L. The relationship of counseling and self-help participation to patient outcomes in DATOS. 1999; 99–112
   Google Scholar
• Peele S. What works in addiction treatment and what doesn't: Is the best therapy no therapy?. International Journal of Addiction 1990; 25: 1409–1419
   PubMed Web of Science ®Google Scholar
• Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Systematic Reviews 2007; 3, CD005032
   Google Scholar
• Fuller J A. Smoking withdrawal and acupuncture. Med J Aust 1982; 1: 28–29
   PubMed Web of Science ®Google Scholar
• Carroll K M, Onken L S. Behavioral therapies for drug abuse. American Journal of Psychiatry 2005; 162: 1452–1460
   PubMed Web of Science ®Google Scholar
• Kadden R M. Behavioral and cognitive-behavioral treatments for alcoholism: Research opportunities. Addictive Behaviors 2001; 26: 489–507
   PubMed Web of Science ®Google Scholar
• Manheimer E, Anderson B J, Stein M D. Use and assessment of complementary and alternative therapies by intravenous drug users. Am J Drug Alcohol Abuse 2003; 29: 401–413
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang X J, Zhao Z L. Recent study on Traditional medicine. Pharm J Chin Pla 2001; 17: 145–147
   Google Scholar
• Attele A S, Wu J A, Yuan C S. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 1999; 58: 1685–1693
   PubMed Web of Science ®Google Scholar
• Gillis C N. Panax ginseng pharmacology: A nitric oxide link. Biochemical Pharmacology 1997; 54: 1–8
   PubMed Web of Science ®Google Scholar
• Cheng R S, Pomeranz B, Yu G. Electroacupuncture treatment of morphine-dependent mice reduces signs of withdrawal, without showing cross-tolerance. Eur J Pharmacol 1980; 68: 477–481
   PubMed Web of Science ®Google Scholar
• Takahashi M, Tokuyama S. Pharmacological and physiological effects of ginseng on actions induced by opioids and psychostimulants. Methods Find Exp Clin Pharmacol 1998; 20: 77–84
   PubMedGoogle Scholar
• Kim H S, Jang C G, Park W K, et al. Blockade by ginseng total saponin of methamphetamine-induced hyperactivity and conditioned place preference in mice. General Pharmacology 1995; 27: 199–204
   Google Scholar
• Kim H S, Kim K S, Oh K W. Inhibition by ginsenosides Rb1 and Rg1 of cocaine-induced hyperactivity, conditioned place preference, and postsynaptic dopamine receptor supersensitivity in mice. Pharmacology, Biochemistry, and Behavior 1999; 63: 407–412
   PubMed Web of Science ®Google Scholar
• Huang Z M. Studies on Ginsenoside inhibited morphine-dependence. Wolrd Phytomedicines 1991; 6: 203–205
   Google Scholar
• Kim H S, Hong Y T, Jang C G. Effects of the ginsenosides Rg1 and Rb1 on morphine-induced hyperactivity and reinforcement in mice. J Pharm Pharmacol 1998; 50: 555–560
   PubMedGoogle Scholar
• Kim H S, Kim K S, Oh K W. Ginseng total saponin inhibits nicotine-induced hyperactivity and conditioned place preference in mice. Journal of Ethnopharmacology 1999; 66: 83–90
   PubMedGoogle Scholar
• Zhao R J, Yoon S S, Lee B H, et al. Acupuncture normalizes the release of accumbal dopamine during the withdrawal period and after the ethanol challenge in chronic ethanol-treated rats. Neurosci Lett 2006; 395: 28–32
   PubMedGoogle Scholar
• Wu C F, Liu Y L, Song M, et al. Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice. Pharmacol Biochem Behav 2003; 76: 103–109
   PubMedGoogle Scholar
• Li Z, Wu C F, Pei G, Guo Y Y, Li X. Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice. Pharmacol Biochem Behav 2000; 66: 595–601
   PubMedGoogle Scholar
• Li Z, Xu N J, Wu C F, et al. Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-mu cells. Neuroreport 2001; 12: 1453–1456
   PubMedGoogle Scholar
• Cairney S, Maruff P, Clough A R. The neurobehavioural effects of kava. Aust N Z J Psychiatry 2002; 36: 657–662
   PubMed Web of Science ®Google Scholar
• Groth-Marnat G, Leslie S, Renneker M. Tobacco control in a traditional Fijian village: Indigenous methods of smoking cessation and relapse prevention. Soc Sci Med 1996; 43: 473–477
   PubMedGoogle Scholar
• Steiner G G. Kava as an anticraving agent: Preliminary data. Pac Health Dialog 2001; 8: 335–339
   PubMedGoogle Scholar
• Bressler R. Herb-drug interactions: Interactions between kava and prescription medications. Geriatrics 2005; 60: 24–25
   PubMed Web of Science ®Google Scholar
• Seitz U, Schule A, Gleitz J. [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Medica 1997; 63: 548–549
   PubMed Web of Science ®Google Scholar
• Gleitz J, Friese J, Beile A, Ameri A, Peters T. Anticonvulsive action of (+/−)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. Euro J Pharmacology 1996; 315: 89–97
   PubMed Web of Science ®Google Scholar
• Baum S S, Hill R, Rommelspacher H. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. Progress Neuropsychopharmacology and Biological Psychiatry 1998; 22: 1105–1120
   PubMed Web of Science ®Google Scholar
• Lude S, Torok M, Dieterle S, et al. Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 2008; 15: 120–131
   PubMed Web of Science ®Google Scholar
• Popik P, Layer R T, Fossom L H, et al. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. J Pharmacol Exp Ther 1995; 275: 753–760
   PubMed Web of Science ®Google Scholar
• Sheppard S G. A preliminary investigation of ibogaine: Case reports and recommendations for further study. Journal of Substance Abuse Treatment 1994; 11: 379–385
   PubMed Web of Science ®Google Scholar
• Jenks C W. Extraction studies of Tabernanthe iboga and Voacanga africana. Nat Prod Lett 2002; 16: 71–76
   PubMed Web of Science ®Google Scholar
• Glick S D, Rossman K, Steindorf S, Maisonneuve I M, Carlson J N. Effects and aftereffects of ibogaine on morphine self-administration in rats. Euro J Pharmacology 1991; 195: 341–345
   PubMed Web of Science ®Google Scholar
• Cappendijk S L, Dzoljic M R. Inhibitory effects of ibogaine on cocaine self-administration in rats. Euro J Pharmacology 1993; 241: 261–265
   PubMed Web of Science ®Google Scholar
• Glick S D, Kuehne M E, Maisonneuve I M, Bandarage U K, Molinari H H. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: Effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res 1996; 719: 29–35
   PubMedGoogle Scholar
• Sershen H, Hashim A, Lajtha A. Ibogaine reduces preference for cocaine consumption in C57BL/6By mice. Pharmacology, Biochemistry, and Behavior 1994; 47: 13–19
   PubMed Web of Science ®Google Scholar
• Sershen H, Hashim A, Harsing L, Lajtha A. Ibogaine antagonizes cocaine-induced locomotor stimulation in mice. Life Sciences 1992; 50: 1079–1086
   PubMed Web of Science ®Google Scholar
• Benwell M E, Holtom P E, Moran R J, Balfour D J. Neurochemical and behavioural interactions between ibogaine and nicotine in the rat. British Journal of Pharmacology 1996; 117: 743–749
   PubMedGoogle Scholar
• Sershen H, Harsing L G, Jr, Hashim A, Lajtha A. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats. Life Sciences 1992; 51: 1003–1011
   PubMedGoogle Scholar
• Yu X, Imam S Z, Newport G D, Slikker W, Jr, Ali S F. Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice. Brain Res 1999; 823: 213–216
   PubMedGoogle Scholar
• Deecher D C, Teitler M, Soderlund D M, et al. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Research 1992; 571: 242–247
   PubMed Web of Science ®Google Scholar
• Sweetnam P M, Lancaster J, Snowman A, et al. Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity. Psychopharmacology (Berl) 1995; 118: 369–376
   PubMed Web of Science ®Google Scholar
• Maisonneuve I M, Mann G L, Deibel C R, Glick S D. Ibogaine and the dopaminergic response to nicotine. Psychopharmacology 1997; 129: 249–256
   PubMed Web of Science ®Google Scholar
• Sershen H, Hashim A, Lajtha A. Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats. Neurochemical Research 1994; 19: 1463–1466
   PubMedGoogle Scholar
• Szumlinski K K, Maisonneuve I M, Glick S D. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine. Eur J Pharmacol 2000; 398: 259–262
   PubMedGoogle Scholar
• Itzhak Y, Ali S F. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain. Annuals of New York Academy Sciences 1998; 844: 245–251
   Google Scholar
• Mah S J, Tang Y, Liauw P E, Nagel J E, Schneider A S. Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release. Brain Res 1998; 797: 173–180
   PubMedGoogle Scholar
• Park J, White A R, Ernst E. New sham method in auricular acupuncture. Arch Intern Med 2001; 161: 894, author reply 895
   PubMedGoogle Scholar
• Leal M B, Michelin K, Souza D O, Elisabetsky E. Ibogaine attenuation of morphine withdrawal in mice: Role of glutamate N-methyl-D-aspartate receptors. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 781–785
   PubMed Web of Science ®Google Scholar
• Abascal K, Yarnell E. Kudzu-the miracle vine. Alternative and Complementary Therapies 2007; 13(2)78–85
   Google Scholar
• Yue H W, Hu X Q. Pharmacologic value of radix Puerariae and puerarine on cardiovascular system. Zhongguo Zhong Xi Yi Jie He Za Zhi 1996; 16: 382–384
   PubMedGoogle Scholar
• Keung W M, Vallee B L. Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters. Proc Natl Acad Sci USA 1993; 90: 10008–10012
   PubMed Web of Science ®Google Scholar
• Heyman G M, Keung W M, Vallee B L. Daidzin decreases ethanol consumption in rats. Alcohol Clin Exp Res 1996; 20: 1083–1087
   PubMedGoogle Scholar
• Overstreet D H, Lee Y W, Rezvani A H, et al. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol Clin Exp Res 1996; 20: 221–227
   PubMedGoogle Scholar
• Benlhabib E, Baker J I, Keyler D E, Singh A K. Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004; 7: 180–186
   PubMed Web of Science ®Google Scholar
• Lin R C, Guthrie S, Xie C Y, et al. Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcoholism: Clinical and Experimental Research 1996; 20: 659–663
   PubMedGoogle Scholar
• Benlhabib E, Baker J I, Keyler D E, Singh A K. Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004; 7: 168–179
   PubMed Web of Science ®Google Scholar
• Overstreet D H, Keung W M, Rezvani A H, Massi M, Lee D Y. Herbal remedies for alcoholism: Promises and possible pitfalls. Alcohol Clin Exp Res 2003; 27: 177–185
   PubMedGoogle Scholar
• Shebek J, Rinbone J P. A pilot study exploring the effect of kudzu root on the drinking habits of patients with chronic alcoholism. Journal of Alternative Complementary Medicine 2000; 6: 45–48
   PubMedGoogle Scholar
• Lukas S E, Penetar D, Berko J, et al. An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcohol Clin Exp Res 2005; 29: 756–762
   PubMed Web of Science ®Google Scholar
• Keung W M, Klyosov A A, Vallee B L. Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters. Proc Natl Acad Sci U S A 1997; 94: 1675–1679
   PubMed Web of Science ®Google Scholar
• Keung W M, Vallee B L. Daidzin: A potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proc Natl Acad Sci U S A 1993; 90: 1247–1251
   PubMed Web of Science ®Google Scholar
• Keung W M, Vallee B L. Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria. Proc Natl Acad Sci U S A 1998; 95: 2198–2203
   PubMedGoogle Scholar
• Keung W M, Vallee B L. Kudzu root: An ancient Chinese source of modern antidipsotropic agents. Phytochemistry 1998; 47: 499–506
   PubMed Web of Science ®Google Scholar
• Keung W M. Anti-dipsotropic isoflavones: The potential therapeutic agents for alcohol dependence. Med Res Rev 2003; 23: 669–696
   PubMedGoogle Scholar
• Shen X L, Witt M R, Nielsen M, Sterner O. Inhibition of [3H] flunitrazepam binding to rat brain membranes in vitro by puerarin and daidzein. Yao Xue Xue Bao 1996; 31: 59–62
   PubMedGoogle Scholar
• Glaser J L. Maharishi Ayurveda: An introduction to recent research. Modern Science and Vedic Science 1988; 2: 89–108
   Google Scholar
• Singh R H. Rasayana,Vajikarana. In History of Medicine in India, P V Sharma. Indian National Science Academy, New Delhi 1992
   Google Scholar
• Nadkarni K M. Indian Materia Medica. Popular Prakashan Private, Bombay 1993
   Google Scholar
• Monier-Williams M. A Sanskrit-English Dictionary. Motilal Banarsidass Publishers Pvt., New Delhi 1997
   Google Scholar
• Archana R, Namasivayam A. Antistressor effect of Withania somnifera. J Ethnopharmacol 1999; 64: 91–93
   PubMed Web of Science ®Google Scholar
• Sudhir S, Budhiraja R D, Miglani G P, et al. Pharmacological studies on leaves of withania somnifera. Planta Medica 1986; 52: 61–63
   Google Scholar
• Bhattacharya S K, Kumar A, Ghosal S. Effects of glycowithanolides from Withania somnifera on animal model of Alzheimer' s disease and perturbed central cholinergic markers of cognition in rats. Phytotherapy Research 1995; 9: 110–113
   Web of Science ®Google Scholar
• Kulkarni S K, Ninan I. Inhibition of morphine tolerance and dependence by Withania somnifera in mice. J Ethnopharmacol 1997; 57: 213–217
   PubMed Web of Science ®Google Scholar
• Andrade C. Indian herbal medicine and the treatment of addictive disorders The UK/European Symposium on Addictive Disorders (UKESAD), (London). 2006
   Google Scholar
• Ussanawarong S, Thesiri T. Effect of Thunbergia Laurifolia Linn on detoxification of parathion in rat. Khon Kaen University Research Journal 2001; 6: 3–13
   Google Scholar
• Ussanawarong S, Thesiri T, Mahakunakorn T, Parasupattana S. Effect of Thunbergia Laurifolia Linn on detoxification of paraquat. Khon Kaen University Research Journal 2000; 5
   Google Scholar
• Wutythamawech W. Encyclopedia of Thai Herbs. OS Printing House, Bangkok 1998; 390–497
   Google Scholar
• Chanawirat A, Toskulkao C, Temcharoen P, Glinsukou T. Protective effect of Thunbergia laurifolia extract on ethanol-induced hepatotoxicity in mice. 2000, Faculty of Graduate Studies (Bangkok, Thailand, Mahidol University)
   Google Scholar
• Pramyothin P, Chirdchupunsare H, Rungsipipat A, Chaichantipyuth C. Hepatoprotective activity of Thunbergia laurifolia Linn extract in rats treated with ethanol: In vitro and in vivo studies. J Ethnopharmacol 2005; 102: 408–411
   PubMed Web of Science ®Google Scholar
• Thongsaard W, Marsden C A, Morris P, Prior M, Shah Y B. Effect of Thunbergia laurifolia, a Thai natural product used to treat drug addiction, on cerebral activity detected by functional magnetic resonance imaging in the rat. Psychopharmacology (Berl) 2005; 180: 752–760
   PubMedGoogle Scholar
• Thongsaard W, Marsden C A. A herbal medicine used in the treatment of addiction mimics the action of amphetamine on in vitro rat striatal dopamine release. Neurosci Lett 2002; 329: 129–132
   PubMedGoogle Scholar
• Kasimu R, Tanaka K, Tezuka Y, et al. Comparative study of seventeen Salvia plants: Aldose reductase inhibitory activity of water and MeOH extracts and liquid chromatography-mass spectrometry (LC-MS) analysis of water extracts. Chem Pharm Bull (Tokyo) 1998; 46: 500–504
   PubMed Web of Science ®Google Scholar
• Colombo G, Agabio R, Lobina C, et al. Salvia miltiorrhiza extract inhibits alcohol absorption, preference, and discrimination in sP rats. Alcohol 1999; 18: 65–70
   PubMed Web of Science ®Google Scholar
• Brunetti G, Serra S, Vacca G, et al. IDN 5082, a standardized extract of Salvia miltiorrhiza, delays acquisition of alcohol drinking behavior in rats. J Ethnopharmacol 2003; 85: 93–97
   PubMedGoogle Scholar
• Vecca G, Colombo G, Brunetti G, et al. Reducing effect of Salvia miltiorrhiza extracts on alcohol intake: Influence of vehicle. Phytotherapy Research 2003; 17: 537–541
   PubMedGoogle Scholar
• Serra S, Vacca G, Tumatis S, et al. Anti-relapse properties of IDN 5082, a standardized extract of Salvia miltiorrhiza, in alcohol-preferring rats. J Ethnopharmacol 2003; 88: 249–252
   PubMedGoogle Scholar
• Lee C M, Wong H N, Chui K Y, et al. Miltirone, a central benzodiazepine receptor partial agonist from a Chinese medicinal herb Salvia miltiorrhiza. Neuroscience Letter 1991; 127: 237–241
   PubMedGoogle Scholar
• Colombo G, Serra S, Vacca G, et al. Indentification of miltirone as active ingredient of Salvia miltiorrhiza responsible for the reducing effect ofd root extracts on alcohol intake in rats. Alcoholism: Clinical and Experimental Research 2006; 30: 754–762
   PubMedGoogle Scholar
• Mostallino M C, Mascia M P, Pisu M G, et al. Inhibition by miltirone of up-regulation of GABAA receptor alpha4 subunit mRNA by ethanol withdrawal in hippocampal neurons. European of Pharmacology 2004; 494: 83–90
   PubMedGoogle Scholar
• Koo B, Kwon T, Kim C. Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglias and mimics the action of amphetamine on in vitro rat striatal dopamine release. Neurochemical Research 2004; 29: 1837–1845
   PubMedGoogle Scholar
• Schultes R E, Hofmann A. The Botany and Chemistry of Hallucinogens. Charles C. Thomas, Springfield, IL 1980
   Google Scholar
• Dobkin de Rios M. Visionary Vine: Hallucinogenic Healing in the Peruvian Amazon. Waveland Press, Prospect Heights 1984
   Google Scholar
• Callaway J C, McKenna D J, Grob C S, et al. Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol 1999; 65: 243–256
   PubMed Web of Science ®Google Scholar
• McKenna D J, Towers G H, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol 1984; 10: 195–223
   PubMed Web of Science ®Google Scholar
• McKenna D J, Peroutka S J. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(−)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin. J Neurosci 1989; 9: 3482–3490
   PubMed Web of Science ®Google Scholar
• Winter J C, Rabin R A. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol Biochem Behav 1988; 30: 617–624
   PubMed Web of Science ®Google Scholar
• Callaway J C, Airaksinen M M, McKenna D J, Brito G S, Grob C S. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology (Berl) 1994; 116: 385–387
   PubMed Web of Science ®Google Scholar
• Mabit M. Takiwasi: Ayahuasca and shamanism in addiction therapy. MAPS Newslettter 1996; 6: 24–27
   Google Scholar
• Grob C S, McKenna D J, Callaway J C, et al. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nerv Ment Dis 1996; 184: 86–94
   PubMed Web of Science ®Google Scholar
• Liu S, Zhou W, Liu H, Yang G, Zhao W. Electroacupuncture attenuates morphine withdrawal signs and c-Fos expression in the central nucleus of the amygdala in freely moving rats. Brain Res 2005; 1044: 155–163
   PubMedGoogle Scholar
• Ge X Q, Zhang H Q, Zhou H Z, Xu Z G, Bian C F. Experimental study of tetrahydroprotoberberines inhibiting morphine withdrawal syndromes. Chinese Journal of Drug Dependence 1999; 8: 178–184
   Google Scholar
• Jin G Z. Discoveries in the voyage of Corydalis research. Shanghai Scientific and Technical Publishers, Shanghai 2001
   Google Scholar
• Mantsch J R, Li S J, Risinger R, et al. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology 2006; 192: 581–591
   Google Scholar
• Jin G Z. (−)- tetrahydropalmatine and its analogues as new dopamine receptor antagonists. TIPS 1987; 8: 81–82
   Google Scholar
• Marcenac F, Jin G Z, Gonon F. Effect of l-tetrahydropalmatine on doapine release and metabolism in the rat striatum. Psychopharmacology 1987; 89: 89–93
   Google Scholar
• Wang Y, Cao X, Li K, Wu G. Relationship between electroacupuncture analgesia and dopamine receptors in nucleus accumbens. Zhongguo Yao Li Xue Bao 1997; 18: 494–496
   PubMedGoogle Scholar
• Martin M I, Lizasoain I, Leza J C. Calcium channel blockers: Effect on morphine-induced hypermotility. Psychopharmacology(Berl) 1990; 101: 267–270
   PubMedGoogle Scholar
• Michaluk J, Karolewicz B, Antkiewicz-Michaluk L, Vetulani J. Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur J Pharmacol 1998; 352: 189–197
   PubMed Web of Science ®Google Scholar
• McLaughlin J L. Peyote: An introduction. Lloydia 1973; 36: 1–8
   PubMedGoogle Scholar
• Borchers A T, Keen C L, Stern J S, Gershwin M E. Inflammation and Native American medicine: The role of botanicals. Am J Clin Nutr 2000; 72: 339–347
   PubMed Web of Science ®Google Scholar
• Aberle D F. The Peyote Religion Among the Navaho, 1st ed. Aldine Publishing Company, Chicago, IL 1966
   Google Scholar
• Shwartz M, Saitz R, Mulvey K, Brannigan P. The value of acupuncture detoxification programs in a substance abuse treatment system. J Subst Abuse Treat 1999; 17: 305–312
   PubMed Web of Science ®Google Scholar
• Stewart O. Peyote Religion: A History, 1st ed. University of Oklahoma Press, Tulsa 1987
   Google Scholar
• Albaugh B J, Anderson P O. Peyote in the treatment of alcoholism among American Indians. Am J Psychiatry 1974; 131: 1247–1250
   PubMed Web of Science ®Google Scholar
• Chuelos N, Blewett D B, Smith C M, Hoffer A. Use of dl-lysergic acid diethylamide in the treatment of alcoholism. Am. J. Stud. Alcohol. 1959; 20: 577
   Web of Science ®Google Scholar
• Maclean J R, Macdonald D C, Byrne U P, Hubbard A M. The use of LSD-25 in the treatment of alcoholism and other psychiatric problems. Q J Stud Alcohol 1961; 22: 34–45
   PubMedGoogle Scholar
• Smith C M. A new adjunct to the treatment of alcoholism: The hallucinogenic drugs. Am. J. Stud. Alcohol. 1959; 406
   Google Scholar
• Halpern J H, Sherwood A R, Hudson J I, Yurgelun-Todd D, Pope H G, Jr. Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry 2005; 58: 624–631
   PubMed Web of Science ®Google Scholar
• Maciocia G. The foundation of Chinese medicine. Churchill Livingstone, New York 1989
   Google Scholar
• Ulett G A, Han S, Han J S. Electroacupuncture: Mechanisms and clinical application. Biol Psychiatry 1998; 44: 129–138
   PubMed Web of Science ®Google Scholar
• Wen H L. Acupuncture and electrical stimulation (AES) out patient detoxification. Mod Med Asia 1979; 15: 39–43
   Google Scholar
• Smith M O, Khan I. An acupuncture programme for the treatment of drug-addicted persons. 1988; 35–41
   Google Scholar
• Renaud J, Renaud M. Big publisher explains acu detox to docs Guidepoints: Acupuncture in Recovery. 1998; p5
   Google Scholar
• Jordan J B. Acupuncture treatment for opiate addiction: A systematic review. 2006; 309–14
   Google Scholar
• Zhang X F, Li X, Feng C X. Clinical study on electro-acupuncture treatment for protracted withdrawal syndromes of opiate dependence. Chin J Drug Depend 1998; 7: 152–155
   Google Scholar
• Fung K P, Choa G H, Choy Y M, et al. Effect of electro-acupuncture on behavioral responses and plasma levels of ACTH and TSH in naloxone-induced morphine withdrawal in rats. Am J Chin Med 1980; 8: 167–169
   PubMed Web of Science ®Google Scholar
• Kim M R, Kim S J, Lyu Y S, et al. Effect of acupuncture on behavioral hyperactivity and dopamine release in the nucleus accumbens in rats sensitized to morphine. Neurosci Lett 2005; 387: 17–21
   PubMed Web of Science ®Google Scholar
• Wang B, Luo F, Xia Y Q, Han J S. Peripheral electric stimulation inhibits morphine-induced place preference in rats. Neuroreport 2000; 11: 1017–1020
   PubMedGoogle Scholar
• Avants S K, Margolin A, Holford T R, Kosten T R. A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med 2000; 160: 2305–2312
   PubMed Web of Science ®Google Scholar
• Konefal J, Duncan R, Clemence C. The impact of the addition of an acupuncture treatment program to an existing metro-Dade County outpatient substance abuse treatment facility. J Addict Dis 1994; 13: 71–99
   PubMedGoogle Scholar
• Gurevich M I, Duckworth D, Imhof J E, Katz J L. Is auricular acupuncture beneficial in the inpatient treatment of substance-abusing patients? A pilot study. J Subst Abuse Treat 1996; 13: 165–171
   PubMed Web of Science ®Google Scholar
• Lipton D S, Brewington V, Smith M. Acupuncture for crack-cocaine detoxification: Experimental evaluation of efficacy. Journal of Substance Abuse Treatment 1994; 11: 205–215
   PubMed Web of Science ®Google Scholar
• Avants S K, Margolin A, Chang P, Kosten T R, Birch S. Acupuncture for the treatment of cocaine addiction. Investigation of a needle puncture control. J Subst Abuse Treat 1995; 12: 195–205
   PubMed Web of Science ®Google Scholar
• D'Alberto A. Auricular acupuncture in the treatment of cocaine/crack abuse: A review of the efficacy, the use of the National Acupuncture Detoxification Association protocol, and the selection of sham points. J Altern Complement Med 2004; 10: 985–1000
   PubMed Web of Science ®Google Scholar
• Bier I D, Wilson J, Studt P, Shakleton M. Auricular acupuncture, education, and smoking cessation: A randomized, sham-controlled trial. Am J Public Health 2002; 92: 1642–1647
   PubMed Web of Science ®Google Scholar
• Clavel-Chapelon F, Paoletti C, Benhamou S. Smoking cessation rates 4 years after treatment by nicotine gum and acupuncture. Preventive Medcine 1997; 26: 25–28
   PubMed Web of Science ®Google Scholar
• Chae Y, Yang C H, Kwon Y K, et al. Acupuncture attenuates repeated nicotine-induced behavioral sensitization and c-Fos expression in the nucleus accumbens and striatum of the rat. Neurosci Lett 2004; 358: 87–90
   PubMedGoogle Scholar
• Gaa'l C L, Freebairn C. Ear-acupuncture relaxation therapy in alcoholics. Report on a follow-up survey. Med J Aust 1979; 2: 179–180
   PubMed Web of Science ®Google Scholar
• Bullock M L, Umen A J, Culliton P D, Olander R T. Acupuncture treatment of alcoholic recidivism: A pilot study. Alcohol Clin Exp Res 1987; 11: 292–295
   PubMed Web of Science ®Google Scholar
• Lewenberg A. Electroacupuncture and antidepressant treatment of alcoholism in a private practice. Clin Ther 1985; 7: 611–617
   PubMed Web of Science ®Google Scholar
• Kunz S, Schulz M, Lewitzky M, Driessen M, Rau H. Ear acupuncture for alcohol withdrawal in comparison with aromatherapy: A randomized-controlled trial. Alcohol Clin Exp Res 2007; 31: 436–442
   PubMed Web of Science ®Google Scholar
• Rossetti Z L, Isola D, De Vry J, Fadda F. Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal. Neuropharmacology 1999; 38: 1361–1369
   PubMedGoogle Scholar
• Weiss F, Porrino L J. Behavioral neurobiology of alcohol addiction: Recent advances and challenges. J Neurosci 2002; 22: 3332–3337
   PubMed Web of Science ®Google Scholar
• Zhuang T X, Chen X G, Jiang G H. Treatment of heroin addict with acupucture and herbal medicine: An observation of 25 cases. J Guangdong Coll Tradit Chin Med 1995; 12: 33–35
   Google Scholar